Year: 2021

DENVER, Dec. 29, 2021 (GLOBE NEWSWIRE) — Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (“CPH” or the “Company”), a leading provider of concrete pumping and waste management services in the U.S. and U.K., will hold a conference call on Wednesday, January 12, 2022, at 5:00 p.m. Eastern time to discuss its financial results for the fourth quarter and fiscal year ended October 31, 2021. The Company will report its financial results in a press release prior to the conference call. CPH’s CEO Bruce Young and CFO Iain Humphries will host the conference call, followed by a question and answer period. Date: Wednesday, January 12, 2022Time: 5:00 p.m. Eastern time (3:00 p.m. Mountain time)Toll-free dial-in number: 1-877-407-9039International dial-in number: 1-201-689-8470Conference ID: 13725805 Please call the conference telephone number...

Mullen and DSA will work together on developing Over the Air (OTA) technology for vehicle system diagnostics protocols and tools to be used in production and aftersales of the Mullen FIVE EV Crossover. The encompassing collaboration will be focused on the creation of a platform for smart vehicle grid, remote diagnostics, and telematics for Mullen Automotive.Mullen & DSA Systems announce partnership for OTA technology and vehicles systems diagnosticsDSA Systems will be developing Over the Air (OTA) technology and diagnostic systems for the upcoming Mullen FIVE program.BREA, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, announces today a strategic partnership with DSA Systems...

CARLSBAD, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, announces that they will present at the H.C. Wainwright BIOCONNECT Virtual Conference taking place January 10-13, 2022, and at Biotech Showcase taking place January 10-12, 2022. The Palisade Bio management team also will be hosting investor meetings during that period and talking about their lead program, LB1148. LB1148 has shown significant results in a Phase 2 trial with a 1.1-day improvement in return to bowel function following GI surgery in the mean. Details of the presentations are as follows:Event: H.C. Wainwright BIOCONNECT Virtual ConferenceDate: January 10-13, 2022Time: Presentation available starting at...

Company Expects Fourth Quarter 2021 Revenue to Exceed $2 Million; Highest Quarterly Revenue in Company History LOS ANGELES, Dec. 29, 2021 (GLOBE NEWSWIRE) — Barfresh Food Group Inc. (the “Company” or “Barfresh”) (OTCQB: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, today announced it completed a reverse stock split of its shares of common stock at a ratio of 1-for-13 (1:13). The Company’s stock will begin trading on a post-split basis on the OTCQB at the open of trading on December 29, 2021 under the temporary trading symbol “BRFHD”. The “D” lettering will be removed within 20 business days if the stock is still trading on the OTCQB, or upon the listing of the Company’s common stock on a National Exchange, whichever comes first. At that time, the Company’s trading symbol will revert back to “BRFH.” The...

SAN CLEMENTE, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the J.P. Morgan 40th Annual Healthcare Conference, held virtually January 10-13, 2022. ICU Medical’s presentation will be on Wednesday, January 12, 2022 at 10:30 a.m. PST (1:30 p.m. EST). The presentation will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay. About ICU Medical, Inc. ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion therapy,...

La Coste Facility on Track and Expansion into Las Vegas to Serve New Markets and Geographic Reach to the West Coast DALLAS, TX, Dec. 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused, commercially operational RAS (Recirculating Aquaculture System), today announced the Company’s ongoing sales of live shrimp to Gulf Seafood Inc. (GSI) have continued ramping up following the first commercial deliveries of live shrimp to customers in November. These deliveries are part of the previously announced purchase agreement signed in October for a three-month trial and delivery of 25,000 pounds of live shrimp which GSI will purchase, distribute and market. The Company said increasing demand for smaller sized shrimp...

Vancouver, BC, Dec. 29, 2021 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company” or “Skyharbour”) is pleased to announce it has closed its non-brokered private placement financing for total gross proceeds of CAD $500,000 (the “Private Placement”). The majority of this smaller financing was led by insider participation with an independent director providing the lead order. Skyharbour has allotted and issued 1,000,000 units (the “Units”) at a price of CAD $0.50 per Unit. Each Unit is comprised of one flow-through common share and one-half of one warrant (each whole, a “Warrant”). Each Warrant will entitle the holder to purchase one non-flow through common share for a period of three (3) years at a price of CAD $0.75 per share.  The Company intends to use the proceeds from this...

29 December 2021, 14:15 CET ArcelorMittal (the ‘Company’) today announces that it has completed the fifth share buyback program announced on 17 November 2021 under the authorization given by the annual general meeting of shareholders of 8 June 2021 (the ‘2021 AGM Authorization’). By market close on 28 December 2021, ArcelorMittal had repurchased 34,080,049 shares for a total value of €885,729,034.96 (equivalent to US$999,999,819.63) at an approximate average price per share of €25.99. All details are available on the Company’s website at: https://corporate.arcelormittal.com/investors/equity-investors/share-buyback-program. ENDS About ArcelorMittal ArcelorMittal is the world’s leading steel and mining company, with a presence in 60 countries and primary steelmaking facilities in 17 countries. In 2020, ArcelorMittal had revenues...

REDWOOD CITY, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will participate in the upcoming 40th Annual J.P. Morgan Healthcare Conference. Seer’s management is scheduled to present and participate in a Q&A session on Monday, January 10 at 8:15 a.m. Pacific Time / 11:15 a.m. Eastern Time. A live webcast of the virtual session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference. About Seer Seer™ is a life sciences company developing transformative products that open a new gateway to the proteome. Seer is commercializing its Proteograph™ Product Suite, an integrated solution...